"Designing Growth Strategies is in our DNA"

Colorectal Cancer Screening Market Size, Share & Industry Analysis, By Type (Stool-based (Fecal Immunochemical Test (FIT), Fecal Occult Blood Test (FOBT), and Stool-DNA Test), Colonoscopy, and Others), By End-user (Hospitals & Clinics, Clinical Laboratories, Diagnostics Imaging Centers, and Others), and Regional Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI101144

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 4.1% from 2024-2032

Unit

Value (USD billion)

Segmentation

By Type

  • Stool-based
    • Fecal Immunochemical Test (FIT)
    • Fecal Occult Blood Test (FOBT)
    • Stool-DNA Test
  • Colonoscopy
  • Others

By End-user

  • Hospitals & Clinics
  • Clinical Laboratories
  • Diagnostic Imaging Centers
  • Others

By Geography

  • North America (By Type, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Type, End-user, and Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Type, End-user, and Country/Sub-region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Type, End-user, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, End-user, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • 2019-2032
  • 2023
  • 2019-2022
  • 140
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase